Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX
Clinical trial NCT03555123 · UNKNOWN
Trial details
- NCT number
- NCT03555123
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-11
- Primary completion
- 2022-01-30
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.